
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis
Rahul Shivahare, Preeti Vishwakarma, N. Parmar, et al.
PLoS ONE (2014) Vol. 9, Iss. 4, pp. e94596-e94596
Open Access | Times Cited: 43
Rahul Shivahare, Preeti Vishwakarma, N. Parmar, et al.
PLoS ONE (2014) Vol. 9, Iss. 4, pp. e94596-e94596
Open Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis
Preeti Vishwakarma, N. Parmar, Pawan Kumar Yadav, et al.
Journal of Molecular Medicine (2016) Vol. 94, Iss. 6, pp. 695-710
Closed Access | Times Cited: 10
Preeti Vishwakarma, N. Parmar, Pawan Kumar Yadav, et al.
Journal of Molecular Medicine (2016) Vol. 94, Iss. 6, pp. 695-710
Closed Access | Times Cited: 10
Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis
Rohit Kumar Tiwari, Pragya Chandrakar, Chhedi Lal Gupta, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107181-107181
Closed Access | Times Cited: 10
Rohit Kumar Tiwari, Pragya Chandrakar, Chhedi Lal Gupta, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107181-107181
Closed Access | Times Cited: 10
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen
Bob Milley, Radwan Kiwan, Gary Ott, et al.
Bioconjugate Chemistry (2016) Vol. 27, Iss. 5, pp. 1293-1304
Open Access | Times Cited: 9
Bob Milley, Radwan Kiwan, Gary Ott, et al.
Bioconjugate Chemistry (2016) Vol. 27, Iss. 5, pp. 1293-1304
Open Access | Times Cited: 9
Evaluation of Lsa46 and Lsa77 Leptospiral Proteins for Their Immunoprotective Activities in Hamster Model of Leptospirosis
Aline F. Teixeira, Luis G. V. Fernandes, Antônio Francisco de Souza Filho, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-13
Open Access | Times Cited: 9
Aline F. Teixeira, Luis G. V. Fernandes, Antônio Francisco de Souza Filho, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-13
Open Access | Times Cited: 9
Immune response to recombinant Leishmania infantum lipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB /c mice
Leila Pirdel, Ahmad Zavaran Hosseini
Parasite Immunology (2016) Vol. 39, Iss. 3
Closed Access | Times Cited: 8
Leila Pirdel, Ahmad Zavaran Hosseini
Parasite Immunology (2016) Vol. 39, Iss. 3
Closed Access | Times Cited: 8
Platelet-Activating Factor Receptor Contributes to Antileishmanial Function of Miltefosine
Pallavi R. Gangalum, Waldionê de Castro, Leda Quércia Vieira, et al.
The Journal of Immunology (2015) Vol. 194, Iss. 12, pp. 5961-5967
Open Access | Times Cited: 7
Pallavi R. Gangalum, Waldionê de Castro, Leda Quércia Vieira, et al.
The Journal of Immunology (2015) Vol. 194, Iss. 12, pp. 5961-5967
Open Access | Times Cited: 7
Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B
Shauna McQuarrie, Ken Kasper, Dana C. Moffatt, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2015) Vol. 26, Iss. 6, pp. 325-329
Open Access | Times Cited: 7
Shauna McQuarrie, Ken Kasper, Dana C. Moffatt, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2015) Vol. 26, Iss. 6, pp. 325-329
Open Access | Times Cited: 7
The Effect of Different Immunization Cycles of a Recombinant Mucin1-Maltose-Binding Protein Vaccine on T Cell Responses to B16-MUC1 Melanoma in Mice
Hongyue Zhou, Zenan Zhang, Guomu Liu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5810-5810
Open Access | Times Cited: 7
Hongyue Zhou, Zenan Zhang, Guomu Liu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5810-5810
Open Access | Times Cited: 7
A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model
Fabiana Rodrigues de Santana, Danielle A. M. da Silva, Simone Katz, et al.
Parasitology Research (2022) Vol. 121, Iss. 10, pp. 2849-2860
Closed Access | Times Cited: 4
Fabiana Rodrigues de Santana, Danielle A. M. da Silva, Simone Katz, et al.
Parasitology Research (2022) Vol. 121, Iss. 10, pp. 2849-2860
Closed Access | Times Cited: 4
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model
Lívia M. Carvalho, Miriã Rodrigues Gusmão, Ana Flávia Pereira Costa, et al.
Parasitology (2021) Vol. 149, Iss. 3, pp. 371-379
Open Access | Times Cited: 5
Lívia M. Carvalho, Miriã Rodrigues Gusmão, Ana Flávia Pereira Costa, et al.
Parasitology (2021) Vol. 149, Iss. 3, pp. 371-379
Open Access | Times Cited: 5
Impelling TLR9 : Road to perspective vaccine for visceral leishmaniasis
Rohit Kumar Tiwari, Chhedi Lal Gupta, Preeti Bajpai
Drug Development Research (2020) Vol. 83, Iss. 2, pp. 222-224
Closed Access | Times Cited: 3
Rohit Kumar Tiwari, Chhedi Lal Gupta, Preeti Bajpai
Drug Development Research (2020) Vol. 83, Iss. 2, pp. 222-224
Closed Access | Times Cited: 3
Análise de imunogenicidade e proteção gerada pelos imunógenos de terceira geração pVAX1-FSD e pVAX1-SP contra a leishmaniose tegumentar americana experimental
Bruno Luiz Soares Campos
(2015)
Open Access | Times Cited: 2
Bruno Luiz Soares Campos
(2015)
Open Access | Times Cited: 2
Emerging Concepts in Leishmania Vaccine Adjuvants
Amrita Das, Nahid Ali
(2023), pp. 427-449
Closed Access | Times Cited: 1
Amrita Das, Nahid Ali
(2023), pp. 427-449
Closed Access | Times Cited: 1
ReducedTrichomonas vaginalisviability in mice pretreated with parasite DNA
Marco Antonio Barajas-Mendiola, Laura E. Castellano, Miriam Barrios‐Rodiles, et al.
Parasitology (2019) Vol. 146, Iss. 13, pp. 1636-1645
Closed Access | Times Cited: 2
Marco Antonio Barajas-Mendiola, Laura E. Castellano, Miriam Barrios‐Rodiles, et al.
Parasitology (2019) Vol. 146, Iss. 13, pp. 1636-1645
Closed Access | Times Cited: 2
Host-directed antileishmanial interventions: Harvesting unripe fruits to reach fruition
Anuradha Seth, S.K. Kar
International Reviews of Immunology (2022) Vol. 42, Iss. 3, pp. 217-236
Closed Access | Times Cited: 2
Anuradha Seth, S.K. Kar
International Reviews of Immunology (2022) Vol. 42, Iss. 3, pp. 217-236
Closed Access | Times Cited: 2
Miltefosineto Antileishmanial Function of Platelet-Activating Factor Receptor
Bhaskar Saha, Ranadhir Dey, Luís Rivas, et al.
(2015)
Closed Access
Bhaskar Saha, Ranadhir Dey, Luís Rivas, et al.
(2015)
Closed Access
Avaliação e caracterização de candidatos vacinais voltados para o controle da leptospirose.
Aline Rodrigues Florencio Teixeira
(2016)
Open Access
Aline Rodrigues Florencio Teixeira
(2016)
Open Access